Cargando…
Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling
Diabetic nephropathy (DN) is a chronic low-grade inflammatory disease. Oxidative stress and nuclear factor kappa B (NF-κB) signaling play an important role in the pathogenesis of DN. Short-chain fatty acids (SCFAs) produced from carbohydrate fermentation in the gastrointestinal tract exert positive...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422068/ https://www.ncbi.nlm.nih.gov/pubmed/32831998 http://dx.doi.org/10.1155/2020/4074832 |
_version_ | 1783570000570744832 |
---|---|
author | Huang, Wei Man, Yi Gao, Chenlin Zhou, Luping Gu, Junling Xu, Huiwen Wan, Qin Long, Yang Chai, Li Xu, Youhua Xu, Yong |
author_facet | Huang, Wei Man, Yi Gao, Chenlin Zhou, Luping Gu, Junling Xu, Huiwen Wan, Qin Long, Yang Chai, Li Xu, Youhua Xu, Yong |
author_sort | Huang, Wei |
collection | PubMed |
description | Diabetic nephropathy (DN) is a chronic low-grade inflammatory disease. Oxidative stress and nuclear factor kappa B (NF-κB) signaling play an important role in the pathogenesis of DN. Short-chain fatty acids (SCFAs) produced from carbohydrate fermentation in the gastrointestinal tract exert positive regulatory effects on inflammation and kidney injuries. However, it is unclear whether SCFAs can prevent and ameliorate DN. In the present study, we evaluated the role and mechanism of the three main SCFAs (acetate, propionate, and butyrate) in high-fat diet (HFD) and streptozotocin- (STZ-) induced type2 diabetes (T2D) and DN mouse models and in high glucose-induced mouse glomerular mesangial cells (GMCs), to explore novel therapeutic strategies and molecular targets for DN. We found that exogenous SCFAs, especially butyrate, improved hyperglycemia and insulin resistance; prevented the formation of proteinuria and an increase in serum creatinine, urea nitrogen, and cystatin C; inhibited mesangial matrix accumulation and renal fibrosis; and blocked NF-κB activation in mice. SCFAs also inhibited high glucose-induced oxidative stress and NF-κB activation and enhanced the interaction between β-arrestin-2 and I-κBα in GMCs. Specifically, the beneficial effects of SCFAs were significantly facilitated by the overexpression GPR43 or imitated by a GPR43 agonist but were inhibited by siRNA-GPR43 in GMCs. These results support the conclusion that SCFAs, especially butyrate, partially improve T2D-induced kidney injury via GPR43-mediated inhibition of oxidative stress and NF-κB signaling, suggesting SCFAs may be potential therapeutic agents in the prevention and treatment of DN. |
format | Online Article Text |
id | pubmed-7422068 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-74220682020-08-20 Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling Huang, Wei Man, Yi Gao, Chenlin Zhou, Luping Gu, Junling Xu, Huiwen Wan, Qin Long, Yang Chai, Li Xu, Youhua Xu, Yong Oxid Med Cell Longev Research Article Diabetic nephropathy (DN) is a chronic low-grade inflammatory disease. Oxidative stress and nuclear factor kappa B (NF-κB) signaling play an important role in the pathogenesis of DN. Short-chain fatty acids (SCFAs) produced from carbohydrate fermentation in the gastrointestinal tract exert positive regulatory effects on inflammation and kidney injuries. However, it is unclear whether SCFAs can prevent and ameliorate DN. In the present study, we evaluated the role and mechanism of the three main SCFAs (acetate, propionate, and butyrate) in high-fat diet (HFD) and streptozotocin- (STZ-) induced type2 diabetes (T2D) and DN mouse models and in high glucose-induced mouse glomerular mesangial cells (GMCs), to explore novel therapeutic strategies and molecular targets for DN. We found that exogenous SCFAs, especially butyrate, improved hyperglycemia and insulin resistance; prevented the formation of proteinuria and an increase in serum creatinine, urea nitrogen, and cystatin C; inhibited mesangial matrix accumulation and renal fibrosis; and blocked NF-κB activation in mice. SCFAs also inhibited high glucose-induced oxidative stress and NF-κB activation and enhanced the interaction between β-arrestin-2 and I-κBα in GMCs. Specifically, the beneficial effects of SCFAs were significantly facilitated by the overexpression GPR43 or imitated by a GPR43 agonist but were inhibited by siRNA-GPR43 in GMCs. These results support the conclusion that SCFAs, especially butyrate, partially improve T2D-induced kidney injury via GPR43-mediated inhibition of oxidative stress and NF-κB signaling, suggesting SCFAs may be potential therapeutic agents in the prevention and treatment of DN. Hindawi 2020-08-01 /pmc/articles/PMC7422068/ /pubmed/32831998 http://dx.doi.org/10.1155/2020/4074832 Text en Copyright © 2020 Wei Huang et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Huang, Wei Man, Yi Gao, Chenlin Zhou, Luping Gu, Junling Xu, Huiwen Wan, Qin Long, Yang Chai, Li Xu, Youhua Xu, Yong Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling |
title | Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling |
title_full | Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling |
title_fullStr | Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling |
title_full_unstemmed | Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling |
title_short | Short-Chain Fatty Acids Ameliorate Diabetic Nephropathy via GPR43-Mediated Inhibition of Oxidative Stress and NF-κB Signaling |
title_sort | short-chain fatty acids ameliorate diabetic nephropathy via gpr43-mediated inhibition of oxidative stress and nf-κb signaling |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422068/ https://www.ncbi.nlm.nih.gov/pubmed/32831998 http://dx.doi.org/10.1155/2020/4074832 |
work_keys_str_mv | AT huangwei shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT manyi shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT gaochenlin shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT zhouluping shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT gujunling shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT xuhuiwen shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT wanqin shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT longyang shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT chaili shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT xuyouhua shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling AT xuyong shortchainfattyacidsamelioratediabeticnephropathyviagpr43mediatedinhibitionofoxidativestressandnfkbsignaling |